PH+ MIXED PHENOTYPE ACUTE LEUKEMIA (MPAL)

Clinical trials for PH+ MIXED PHENOTYPE ACUTE LEUKEMIA (MPAL) explained in plain language.

Never miss a new study

Get alerted when new PH+ MIXED PHENOTYPE ACUTE LEUKEMIA (MPAL) trials appear

Sign up with your email to follow new studies for PH+ MIXED PHENOTYPE ACUTE LEUKEMIA (MPAL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

New hope for kids battling leukemia that Won't quit

Disease control Terminated

This study tested a drug called ponatinib, given with standard chemotherapy, for children and young adults up to age 21 with a specific type of leukemia that had come back or stopped responding to other treatments. The main goals were to find a safe dose and see if the combinatio…

Matched conditions: PH+ MIXED PHENOTYPE ACUTE LEUKEMIA (MPAL)

Phase: PHASE1, PHASE2 • Sponsor: Takeda • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

PH+ MIXED PHENOTYPE ACUTE LEUKEMIA (MPAL)

Get alerted when new PH+ MIXED PHENOTYPE ACUTE LEUKEMIA (MPAL) trials appear

New hope for kids battling leukemia that Won't quit